Standaard Boekhandel gebruikt cookies en gelijkaardige technologieën om de website goed te laten werken en je een betere surfervaring te bezorgen.
Hieronder kan je kiezen welke cookies je wilt inschakelen:
Standaard Boekhandel gebruikt cookies en gelijkaardige technologieën om de website goed te laten werken en je een betere surfervaring te bezorgen.
We gebruiken cookies om:
De website vlot te laten werken, de beveiliging te verbeteren en fraude te voorkomen
Inzicht te krijgen in het gebruik van de website, om zo de inhoud en functionaliteiten ervan te verbeteren
Je op externe platformen de meest relevante advertenties te kunnen tonen
Je cookievoorkeuren
Standaard Boekhandel gebruikt cookies en gelijkaardige technologieën om de website goed te laten werken en je een betere surfervaring te bezorgen.
Hieronder kan je kiezen welke cookies je wilt inschakelen:
Technische en functionele cookies
Deze cookies zijn essentieel om de website goed te laten functioneren, en laten je toe om bijvoorbeeld in te loggen. Je kan deze cookies niet uitschakelen.
Analytische cookies
Deze cookies verzamelen anonieme informatie over het gebruik van onze website. Op die manier kunnen we de website beter afstemmen op de behoeften van de gebruikers.
Marketingcookies
Deze cookies delen je gedrag op onze website met externe partijen, zodat je op externe platformen relevantere advertenties van Standaard Boekhandel te zien krijgt.
Je kan maximaal 250 producten tegelijk aan je winkelmandje toevoegen. Verwijdere enkele producten uit je winkelmandje, of splits je bestelling op in meerdere bestellingen.
Multidrug-resistant tuberculosis (TB) is caused by bacteria resistant to isoniazid and rifampicin, the two most effective first-line anti-TB drugs, or...Lees meer
Successful drug development relies on accurate and efficient clinical trials to deliver the best and most effective pharmaceuticals and clinical care ...Lees meer
All pharmaceutical products have inherent risks, and their use involves trade-offs between their therapeutic benefits and their risks. However, the pu...Lees meer
Randomized clinical trials (RCTs) are often referred to as the "gold standard" of clinical research. However, in its current state, the U.S. clinical ...Lees meer
There is a void in evidence-based information for making informed decisions on how to optimize care for older adults, particularly those 80 years and ...Lees meer
An ideal health care system relies on efficiently generating timely, accurate evidence to deliver on its promise of diminishing the divide between cli...Lees meer
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infect...Lees meer
In recent years, the costs of new drug development have skyrocketed. The average cost of developing a new approved drug is now estimated to be $1.3 bi...Lees meer
The process of discovering and developing a new drug or therapy is extremely costly and time consuming, and recently, it has been estimated that the c...Lees meer
Today, scores of companies, primarily in the United States and Europe, are offering whole genome scanning services directly to the public. The prolife...Lees meer
The field of endeavors known as "regulatory science" has grown out of the need to link and integrate knowledge within and among basic science research...Lees meer
Tuberculosis (TB) kills approximately 4,500 people worldwide every day. While most cases of TB can be treated with antibiotics, some strains have deve...Lees meer
Investment and innovation in drug research and development (R&D) for highly prevalent chronic diseases has stalled in recent decades, despite half of ...Lees meer
Recent concerns about the unexpected adverse effects of marketed drugs, such as COX-2 (cyclooxygenase-2) inhibitors or specific statins, raise concern...Lees meer
The Food and Drug Administration (FDA) is tasked with ensuring the safety and effectiveness of medicine. FDA's science base must be strong enough to m...Lees meer
Emerging infectious disease threats that may not have available treatments or vaccines can directly affect the security of the world's health since th...Lees meer
The past several decades have been a time of rapid globalization in the development, manufacture, marketing, and distribution of medical products and ...Lees meer
An estimated 8.8 million people fell ill with tuberculosis (TB) in 2010 and 1.4 million died from the disease. Although antibiotics to treat TB were d...Lees meer
Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the ...Lees meer
The development and application of regulatory science - which FDA has defined as the science of developing new tools, standards, and approaches to ass...Lees meer
Biomarkers can be defined as indicators of any biologic state, and they are central to the future of medicine. As the cost of developing drugs has ris...Lees meer
Advances in technologies and knowledge are creating new avenues for research and opportunities for the discovery and clinical development of innovativ...Lees meer
Despite decades of ongoing efforts to improve racial and ethnic diversity in clinical trials, many gaps remain in achieving demographic representation...Lees meer
Approximately 4 million pregnant people in the United States give birth annually, and 70 percent of these individuals take at least one prescription m...Lees meer